A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study

European Heart Journal

Volumn 24, Issue 20, 2003, Pages 1833-1842

  Freeman, Dilys J ^a,c   Samani, Nilesh J ^b   Wilsona, Valerie ^a   McMahon, Alex D ^c   Braund, Peter S ^b   Cheng, Suzanne ^d   Caslake, Muriel J ^e   Packard, Chris J ^e   Gaffney, Dairena ^e  

^a DURHAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d ROCHE MOLECULAR SYSTEMS   (United States)

^e NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

Atherosclerosis; CETP; Enzymes; Genetics; Lipoproteins; WOSCOPS

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PRAVASTATIN;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CETP B1B1 GENE; CETP B1B2 GENE; CETP TAQLB2 GENE; CHOLESTERYL ESTER TRANSFER PROTEIN GENE; CLINICAL STUDY; CONTROLLED STUDY; DOSE RESPONSE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SMOKING; UNITED KINGDOM;

AGED; ANTICHOLESTEREMIC AGENTS; CARDIOVASCULAR DISEASES; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY DISEASE; GENOTYPE; GLYCOPROTEINS; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PRAVASTATIN; RISK FACTORS; SCOTLAND; SMOKING;

EID: 0142104870     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2003.07.001     Document Type: Article

References (36)

1. Ordovas JM, Cupples LA, Corella D et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk. The Framingham Study. Arterioscler Thromb Vasc Biol 2000;20(5):1323-9.
2. Liu S, Schmitz C, Stampfer MJ et al. A prospective study of the TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men. Atherosclerosis 2002; 161:469-74.
3. Drayna D, Lawn R. Multiple RFLPs at the human choLesteryL ester transfer protein (CETP) Locus. Nucleic Acids Res 1987; 15:4698.
4. Freeman DJ, Packard CJ, Shepherd J et al. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin Sci 1990;79:575-81.
5. Kondo I, Berg K, Drayna D et al. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet 1989;35:49-56.
6. McPherson R, Grundy SM, Guerra R et al. Allelic variation in the gene encoding the cholesteryl ester transfer protein is associated with variation in the plasma concentrations of cholesteryl ester transfer protein. J Lipid Res 1996;37:1743-8.
7. Freeman DJ, Griffin BA, Holmes AP et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 1994;14:336-44.
8. Fumeron F, Betoulle D, Luc G et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 1995;96:1664-71.
9. Takahashi K, Jiang X-C, Sakai N et al. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J Clin Invest 1993; 92:2060-4.
10. Agerholm-Larsen B, Nordestgaard BG, Steffensen R et al. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 2000;101:1907-12.
11. Dachet C, Poirier O, Cambien F et al. New functional promoter polymorphisms, CETP/C(·629)A, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels. Role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb Vasc Biol 2000;20:507-15.
12. Klerkx AHEM, Tanck MWT, Kastelein JJP et al. Haplotype analysis of the CETP gene: not TaqIB but the closely linked -629→A polymorphism and a novel promoter variant are independently associated with CETP concentration. Hum Mol Gen 2003; 12(2):111-23.
13. Corbex M, Poirier O, Fumeron F et al. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet Epidemiol 2000;19(1):64-80.
14. Talmud PJ, Edwards KL, Turner CM et al. Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size. Use of a novel tetranucleotide repeat within the CETP promoter. Circulation 2000; 101:2461-6.
15. Kuivenhoven JA, Jukema JW, Zwinderman AH et al., for the Regression Growth Evaluation Statin Study Group. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N Eng J Med 1998; 338:86-93.
16. Brousseau ME, O'Connor JJ, Ordovas JM et al. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency. Veterans Affairs HDL Cholesterol Intervention Trial. Arterioscler Thromb Vasc Biol 2002;22:1148-54.
17. The WOSCOPS Study Group. Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. Am J Cardiol 1995;76:485-91.
18. Shepherd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N Eng J Med 1995;333:1301-7.
19. Packard CJ, O'Reilly DS, Caslake MJ et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med 2000;343(16):1148-55.
20. Lipid Research Clinics Program. Lipid and lipoprotein analysis. Manual of Laboratory Operations Vol. 1. Dept. of Health, Education and Welfare 1974; Publication No. 75-628. National Institutes of Health, Bethesda, MD.
21. Friedlander Y, Kidron M, Castake M et al. Low density lipoprotein particle size and risk factors of insulin resistance syndrome. Atherosclerosis 2000;148:141-9.
22. Kunkel LM, Smith KD, Boyer S et al. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 1977;74:1245-9.
23. Cheng S, Grow MA, Pallaud C et at. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 1999;9(10):936-49.
24. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Human Genet 2001;68:978-89.
25. Lu H, Inazu A, Moriyama Y et al. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism. J Mol Med 2003;81:246-55.
26. Collet X, Tall AR, Serajuddin H et al. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I. J Lipid Res 1999;40:1185-93.
27. Brinton EA, Eisenberg S, Breslow JL. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb 1994;14:707-20.
28. Okumura K, Matsui H, Kamiya H et al. Differential effect of two common polymorphisms in the cholesteryl ester transfer protein gene on low-density lipoprotein particle size. Atherosclerosis 2002; 161:425-31.
29. Dultart RPF, Hoogenberg K, Dikkeschu BD et al. High plasma lipid transfer protein activities and unfavourable lipoprotein changes in cigarette smoking men. Arterioscler Thromb 1994;14:1581-5.
30. Freeman DJ, Griffin BA, Murray E et al. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur J Clin Invest 1993;23:630-40.
31. Freeman DJ, Castake MJ, Griffin BA et al. The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma. Eur J Clin Invest 1998;28(7):584-91.
32. Mero N, Van Tol A, Scheek LM et al. Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities. J Lipid Res 1998; 39:1493-502.
33. Moriguchi EH, Fusegawa Y, Tamachi H et al. Effects of smoking on HDL subfractions in myocardial infarction patients: effects on lecithincholesterol acyl transferase and hepatic lipase. Clin Chim Acta 1990; 195:139-44.
34. McCall MR, van den Berg JJM, Kuypers FA et al. Modification of LCAT activity and HDL structure, new links between cigarette smoke and coronary heart disease. Arterioscler Thromb 1994; 14:248-53.
35. Goldstein MR, Dullaart RPF, Van Tol A et al. Polymorphism of the cholesteryl ester transfer protein gene. Letters to editor. N Eng J Med 1998;338:1624-6.
36. Libby P, Schoenbeck U, Mach F et al. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med 1998;104:14S-8S.